Personalised medicine

Personalised medicine is a high-value field, expected to expand significantly over the coming years. Strong IP strategy is key to successfully protecting emerging innovations that hold the potential to transform lives.  

The number of drug approvals in precision medicine is growing rapidly, yet this progress comes with significant legal and technical challenges. From navigating patent eligibility exclusions, to dealing with issues of ownership of data or divided infringement, while ensuring protection covers the constant evolution of assay platforms, good guidance is vital to success. 

Working with leading universities, research charities and pioneering SMEs, HGF’s large personalised medicine team delivers patent drafting and prosecution, due diligence and freedom to operate programmes, along with management of transactional and contentious matters in this revolutionary field.  

Our attorneys have a deep understanding of the challenges in this area.  With extensive in-house experience, we are able to tap into genuine insights to lead our clients’ IP strategies and advise across multiple jurisdictions. HGF’s perspective as European attorneys can help to identify global opportunities for clients from across the globe.

Latest updates

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

Searching for the distinctive

How to streamline the trade mark selection process by conducting effective, in-house ‘dirty searches’. Selecting the right trade mark for your new healthcare product is a critically important task. Consumers …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article
Event - 26th April 2021

World Intellectual Property Day 2021

World Intellectual Property Day is on 26th April. This year’s theme is IP & SME’s: Taking your ideas to market. World IP day 2021 shines a light on the critical role of …

Event details
Event - 18th May 2021

IP & data protection for alternative proteins: how to protect your products in the EU

‘IP & data protection for alternative proteins: how to protect your products in the EU’ webinar will be held on Tuesday 18th May. Join this webinar by BGP, HGF & …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our personalised medicine specialists.